![Medtronic wins FDA clearance for bone tumor ablation tech](https://startllc.com/wp-content/uploads/2024/03/Medtronic-logo-updated-300x195-1.webp)
Medtronic wins FDA clearance for bone tumor ablation tech
Medtronic (NYSE: MDT)+
announced today that it received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system.
Medtronic (NYSE: MDT)+
announced today that it received FDA 510(k) clearance for its OsteoCool 2.0 bone tumor ablation system.
Boston Scientific (NYSE: BSX)+
announced today that it received FDA approval for its Agent drug-coated balloon (DCB).
Varian announced today that it received FDA 510(k) clearance for its TrueBeam and Edge radiotherapy systems with HyperSight imaging.